BAX (BAX) Stock Price & Analysis
BAX (BAX) rose 1.02% to USD 25.83 as of September 8, 2026 at 03:34 UTC, according to Nexqual real-time market data.
BAX last closed at USD 25.83; the session ranged USD 25.29–26.12 on volume of 3,414,998 shares. Market capitalization is —, with a 52-week range of USD 15.73–30 (NYQ). Source: Nexqual, September 8, 2026 at 03:34 UTC.
Key Statistics (as of September 8, 2026 at 03:34 UTC)
| Price | USD 25.83 |
|---|---|
| Change | ▲ 1.02% (up) |
| Previous Close | USD 25.83 |
| Open | USD 25.83 |
| Day Range | USD 25.29 – 26.12 |
| 52-Week Range | USD 15.73 – 30 |
| Volume | 3,414,998 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (BAX)
Nexqual's technical model rates BAX "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 03:34 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 55.48 (neutral) |
| vs SMA50 | Above (USD 24.72) |
| MACD | 0.21 (positive) |
Analyst Ratings (BAX)
Wall Street analysts rate BAX "None" based on 11 analysts, with a mean price target of USD 28.73 (range USD 23–40), per Nexqual as of September 8, 2026 at 03:34 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 28.73 |
| High Target | USD 40 |
| Low Target | USD 23 |
| Buy / Hold / Sell | 2 / 11 / 0 |
From BAX's Latest SEC 10-K Filing (filed 2026-02-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDX | Becton, Dickinson and Company | USD 184.74 | ▼ 1.48% |
| EW | Edwards Lifesciences Corporatio | USD 89.9 | ▼ 1.01% |
| CAH | Cardinal Health, Inc. | USD 247.18 | ▲ 0.69% |
| BSX | Boston Scientific Corporation | USD 47.8 | ▼ 1.18% |
| SYK | Stryker Corporation | USD 303.13 | ▼ 2.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:34 UTC. This page is informational and not investment advice.